Abstract
The objective of the paper is to study the retinal microstructure and function in a patient with autosomal recessive bestrophinopathy (ARB). Retinal function and morphology assessment in a patient diagnosed with a biallelic mutation in the BEST1 gene (heterozygote mutations: Leu88del17 and A195V) included: full-field electroretinogram (ffERG) and multifocal electroretinogram (mfERG), electro-oculogram (EOG) testing, and imaging with a high-resolution Fourier-domain optical coherence tomography (Fd-OCT) system (UC Davis Medical Center; axial resolution: 4.5 μm, acquisition speed: 9 frames/s, 1,000 A-scans/frame) combined with a flexible scanning head (Bioptigen Inc.). The 11-year old asymptomatic boy showed a well-demarcated retinopathy with deposits. Functional assessment revealed normal visual acuity, reduced central mfERG responses, delayed rod and rod-cone b-wave ffERG responses, and reduced light rise in the EOG. Fd-OCT demonstrated RPE deposits, photoreceptor detachment, elongated and thickened photoreceptor outer segments, but preserved inner retinal layers. In conclusion, ARB associated retinal dystrophy shows functional and morphological changes that overlap with classic Best disease. For the first time, high-resolution imaging provided in vivo evidence of RPE and photoreceptor involvement in ARB.
Keywords: Autosomal recessive bestrophinopathy, ARB, Fourier-domain OCT, Multifocal ERG, Electro-oculogram
Introduction
Retinal dystrophy associated with biallelic mutations in the BEST1 gene was recently described by Burgess et al. and is now referred to as autosomal recessive bestrophinopathy (ARB) [1]. Clinical features of autosomal dominant classic Best disease caused by BEST1 mutations [2–4] and those of ARB have in common deep retinal deposits and reduction of the electro-oculogram (EOG) light rise. In vivo retinal imaging using time-domain optical coherence tomography (OCT) identified in a patient with ARB retinal edema and subretinal fluid between retinal pigment epithelium (RPE) and neurosensory retina [1]. Previous retinal layer analyses were limited by the image resolution of the time-domain OCT instrumentation. Using a higher-resolution Fourier-domain OCT (Fd-OCT) instrument, we demonstrated for the first time significant photoreceptor changes in a case with biallelic BEST1 mutation.
Methods
A healthy and asymptomatic boy was referred to the Ocular Genetics Clinic at The Hospital for Sick Children in Toronto, Canada, for evaluation of ‘retinal flecks’ seen at a routine eye examination at age 11. His maternal side was of English/Dutch/Newfoundland origin; his paternal origin is unknown. His past medical and family history was unrevealing. Written informed consent was obtained from his guardians. The project was approved by The Research Ethics Board at The Hospital for Sick Children and by the UC Davis Institutional Review Board, and conducted in accordance with the Tenets of Helsinki.
Vision function
Vision function assessment included best-corrected monocular distance visual acuity (VA) on a logMAR scale using the backlit Early Treatment Diabetic Retinopathy Study Chart, color vision testing (Hardy–Rand–Rittler pseudoisochromatic plates under standard illumination) and measurement of contrast sensitivity (CS; Pelli–Robson Contrast Sensitivity charts). Monocular static and kinetic visual fields were obtained with the Humphrey Visual Field Analyzer (HFA II; program 24–2; Carl Zeiss Meditec, Inc., Dublin, CA) and Goldmann perimeter (target size III4e, I4e), respectively.
Full-field electroretinogram (ffERG) was recorded according to the ISCEV standard [5]. In addition, a bright flash ERG (244 cd s/m2) was performed under scotopic and photopic conditions. Isolated rod photoreceptor responses were calculated by digitally subtracting the photopic responses from the combined scotopic and photopic response as described by Hood and Birch [6]. The multifocal electroretinogram (mfERG) was recorded with a stimulus-refractor unit (VERIS, vers.5.1, EDI, San Mateo, CA) on 61 scaled hexagons with a maximum flash intensity of 200 cd m−2/75 Hz. Results of ffERG and mfERG were compared with age-matched control data. EOG responses were registered according to the ISCEV standard [7] (recordings were done before the new ISCEV EOG standard from 2006). Autofluorescence imaging was not available. Molecular genetic analyses were provided as a clinical service by the Carver laboratory (Iowa City, IA, USA).
Fourier-domain optical coherence tomography
Retinal image acquisition was achieved using a custom built, high-speed, high-resolution Fd-OCT system [8] (axial resolution: 4.5 μm; acquisition speed: 9 frames/s, 1,000 A-scans/frame) constructed at UC Davis with the scanning head mounted on an articulating arm (Bioptigen Inc., Durham, NC, USA). Horizontal scans of 6 mm length or a volumetric scan series permitting image acquisition over an area of 6 × 6 mm and OCT fundus reconstruction were registered through the macular area. Raw image data were post-processed, and retinal layers were identified as previously described (Fig. 1) [9, 10].
Results
Visual acuity was nearly normal and stable over the past 3 years of our assessment. CS was reduced in both eyes. Detailed results of vision function tests are listed in Table 1.
Table 1.
Normal value (age-matched) |
Right eye | Left eye | |
---|---|---|---|
Visual acuity (logMAR) | 0.00 | 0.05 | 0.0 |
Contrast sensitivity (log) | 1.65 | 1.5 | 1.5 |
Color vision (HRR test) | N | N | |
Visual field sensitivity | |||
Central | NA | Reduced | |
Peripheral | Normal | Normal | |
Full-field ERG responses | Normal range | ||
Rod b-wave | |||
Implicit time (ms) | 101–129 | 132a | 132a |
Amplitude (μV) | 106–384 | 273 | 284 |
Rod/cone a-wave | |||
Implicit time | 17–23 | 21 | 21 |
Amplitude | 150–398 | 332 | 302 |
Rod/cone b-wave | |||
Implicit time | 38–52 | 56a | 56a |
Amplitude | 381–760 | 595 | 560 |
Cone a-wave | |||
Implicit time | 11–15 | 13 | 14 |
Amplitude | 36–104 | 76 | 57 |
Cone b-wave | |||
Implicit time | 30–35 | 33 | 32 |
Amplitude | 111–292 | 195 | 156 |
Flicker | |||
Implicit time | 23–29 | 28 | 28 |
Amplitude | 53–176 | 119 | 91 |
OP sum | |||
Amplitude | 43–249 | 236 | 125 |
Scotopic bright flash | |||
Implicit time | 4.85–6.72 | 5.6 | 5.6 |
Amplitude | 197–465 | 418 | 337 |
Multifocal ERG responses | Reduced and delayed within central 10° | ||
Electro-oculogram (Arden ratio) | ≥2.0 | 1.0 | 1.3 |
HRR, Hardy–Rand–Rittler pseudoisochromatic plates; N, normal; NA, not analyzable
Significantly delayed
Fundus examination revealed multiple yellowish-white, round, partially confluent lesions at the posterior pole and around the optic nerve with a well-demarcated edge. The lesions were predominant around the vascular arcades and the fovea. The left eye showed two areas with subretinal fibrosis (Fig. 2).
Two heterozygous mutations (Leu88del17 and A195V) in the BEST1 gene were identified.
Electrophysiological findings
Full-field ERG revealed delayed rod and rod-cone b-wave responses in both eyes. The rod b-wave responses did not return to baseline within the recording window used. All response amplitudes were within normal limits (Table 1). Isolated rod photoreceptor responses using the bright flash stimulus showed normal implicit time and amplitude. Of interest is the pronounced negativity prior to OP1 in both eyes (Fig. 3). The mfERG responses were reduced and delayed within the central 10° (Fig. 4). EOG revealed a markedly reduced Arden ratio in both eyes with a dark trough after 8 min (amplitude 1.92 μV) and light peak 6 min from the start of the light phase.
Retinal microstructure
Macular scans demonstrated round- or dome-shaped deposits within the RPE reaching into the subretinal space. Large deposits extended up to the OPL in the left eye as shown in Fig. 2b. The RPE itself was thinned throughout the macula. Photoreceptor layers were detached from the RPE as shown in Fig. 2. Photoreceptor outer segments were thicker and elongated compared with normal control data. Small filament-like bridges were visible between the photoreceptor outer segment layer and the RPE. Verhoeff's membrane, the interface between cone photoreceptors and the RPE, was not identifiable in multiple scans of both eyes (Fig. 2). Inner retinal layers were unaffected.
Comment
Retinal dystrophy associated with biallelic mutations in BEST1 is associated with RPE deposits and marked photoreceptor abnormalities. Signs of photoreceptor detachment resembled descriptions of patients with classic Best disease. Retinal imaging using lower-resolution time-domain OCT in patients with Best disease, which does not allow differentiation of photoreceptor layers and RPE, revealed RPE and photoreceptor detachment in those patients [11], accumulation of material on the outer retina, in the subretinal space or between RPE and outer retinal layers associated with subretinal fluid [12].
No histopathological data are available due to the novel ARB phenotype description of BEST1 mutations. Histopathological data from a 27-year-old patient with classic Best disease demonstrated edematous ganglion cell, inner and outer plexiform layers in the central retina, atrophic photoreceptor outer segments, and diffusely abnormal RPE cells loaded with lipofuscin granules [13]. RPE and outer retina abnormalities were more advanced in the macular area with normal-appearing RPE outside the macula in older patients with classic Best disease [14, 15]. Bakall et al. identified an up to 4-fold increase in A2E deposits in RPE cells in a 81-year old patient with Best disease [16]. Analysis of the granules suggested that RPE cells are not able to fully break down phagocytised photoreceptor outer segments [16]. The identified bridges in the patient presented here might represent unshedded disks leading to elongated outer segments.
The protein product bestrophin-1, locates at the baso-lateral plasma membrane of the RPE [17], is thought to play a regulatory role in the Ca2+ activated Cl− channel [18, 19]. Lipofuscin cytotoxicity leads to RPE cell dysfunction with consecutive photoreceptor degeneration [16].
We showed abnormal photoreceptor structure but unchanged inner retinal layers associated with abnormal cone mediated mfERG responses in the central retina. Isolated rod photoreceptor responses indicated by the bright flash ffERG were normal. The ffERG shows a negative ‘response’ prior to OP1. OPs are generated postsynaptic to the photoreceptors, possibly by amacrine, bipolar and/or interplexiform cells [20]. It is proposed that the short-latency scotopic OPs are generated through the cone pathway and the long-latency scotopic OPs through the rod pathways [21]. Therefore, the negativity prior to OP1 might point to changes within the cone pathway.
The rod and rod-cone b-wave implicit times might reflect abnormalities distal to the photoreceptors. The tests we performed cannot rule out focal photoreceptor abnormalities. The bright flash rod response indicates normal global rod photoreceptor function. We are not able to test rod function focally in areas with visible fundus changes and identified abnormalities in Fd-OCT scans. Focal cone photoreceptor function is not isolated either. The mfERG responses are a product of photoreceptor and bipolar cells [22]. Morphological OCT results indicated changes within the outer retina layers including photoreceptors and the interface between cone photoreceptors and the RPE (Verhoeff's membrane) in the scanned macular area. It is quite surprising that the patient's vision is normal despite the photoreceptor detachment from the RPE. From the tests performed, we are not able to determine the functional consequences of the identified morphological changes.
Burgess et al. reported reduced rod and cone ERG responses in all seven patients and delayed scotopic or photopic ERG responses in two and three patients, respectively [1]. Macular function evaluated by pattern ERG was mildly reduced to non-detectable in five patients [1] indicating ganglion cell dysfunction possibly including distal retinal layers [23].
Confirmation of this newly described phenotype associated with biallelic mutations in BEST1 and functional analysis of the mutations will provide longitudinal information about photoreceptor morphology and function. High-resolution macular imaging together with electrophysiological testing will be important for advancing our understanding of this disease process.
Acknowledgments
This study was supported by NIH/NEI grant 014743 (JSW), Research to Prevent Blindness Senior Scientist Award (JSW), the Mira Godard Fund (EH) and the Albrecht Fund (JSW) in collaboration with Bioptigen, Inc. We thank Yesmino Elia for study coordination, Carmelina Trimboli-Heidler for fundus photography, and Tom Wright and Carole Panton for help with data analysis.
Abbreviations
- EOG
Electro-oculogram
- Fd-OCT
Fourier-domain optical coherence tomography
- ffERG
Full-field electroretinogram
- ISCEV
International Society for Clinical Electrophysiology of Vision
- mfERG
Multifocal electroretinogram
- RPE
Retinal pigment epithelium
Contributor Information
Christina Gerth, Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Robert J. Zawadzki, Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Canada
John S. Werner, Department of Ophthalmology & Vision Science, Vision Science and Advanced Retinal Imaging Laboratory (VSRI), University of California, Davis, USA
Elise Héon, Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
References
- 1.Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82:19–31. doi: 10.1016/j.ajhg.2007.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19:241–247. doi: 10.1038/915. [DOI] [PubMed] [Google Scholar]
- 3.Stohr H, Marquardt A, Rivera A, et al. A gene map of the Best's vitelliform macular dystrophy region in chromosome 11q12–q13.1. Genome Res. 1998;8:48–56. doi: 10.1101/gr.8.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Marquardt A, Stohr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease) Hum Mol Genet. 1998;7:1517–1525. doi: 10.1093/hmg/7.9.1517. [DOI] [PubMed] [Google Scholar]
- 5.Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update) Doc Ophthalmol. 2004;108:107–114. doi: 10.1023/b:doop.0000036793.44912.45. [DOI] [PubMed] [Google Scholar]
- 6.Hood DC, Birch DG. Assessing abnormal rod photoreceptor activity with the a-wave of the electroretinogram: applications and methods. Doc Ophthalmol. 1996;92:253–267. doi: 10.1007/BF02584080. [DOI] [PubMed] [Google Scholar]
- 7.Marmor MF, Zrenner E. Standard for clinical electro-oculography. International society for clinical electrophysiology of vision. Arch Ophthalmol. 1993;111:601–604. doi: 10.1001/archopht.1993.01090050035023. [DOI] [PubMed] [Google Scholar]
- 8.Wojtkowski M, Leitgeb R, Kowalczyk A, et al. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt. 2002;7:457–463. doi: 10.1117/1.1482379. [DOI] [PubMed] [Google Scholar]
- 9.Zawadzki RJ, Jones SM, Olivier SS, et al. Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in-vivo imaging. Opt Express. 2005;13:8532–8546. doi: 10.1364/opex.13.008532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zawadzki RJ, Fuller AR, Wiley DF, et al. Adaptation of a support vector machine algorithm for segmentation and visualization of retinal structures in volumetric optical coherence tomography data sets. J Biomed Opt. 2007;12:041206. doi: 10.1117/1.2772658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wabbels B, Preising MN, Kretschmann U, et al. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1453–1466. doi: 10.1007/s00417-006-0286-6. [DOI] [PubMed] [Google Scholar]
- 12.Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology. 2006;113:1392–1400. doi: 10.1016/j.ophtha.2006.03.023. [DOI] [PubMed] [Google Scholar]
- 13.Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1108–1114. doi: 10.1001/archopht.1982.01030040086016. [DOI] [PubMed] [Google Scholar]
- 14.Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1115–1121. doi: 10.1001/archopht.1982.01030040093017. [DOI] [PubMed] [Google Scholar]
- 15.Mullins RF, Oh KT, Heffron E, et al. Late development of vitelliform lesions and flecks in a patient with Best disease: clinicopathologic correlation. Arch Ophthalmol. 2005;123:1588–1594. doi: 10.1001/archopht.123.11.1588. [DOI] [PubMed] [Google Scholar]
- 16.Bakall B, Radu RA, Stanton JB, et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2) Exp Eye Res. 2007;85:34–43. doi: 10.1016/j.exer.2007.02.018. [DOI] [PubMed] [Google Scholar]
- 17.Marmorstein AD, Marmorstein LY, Rayborn M, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA. 2000;97:12758–12763. doi: 10.1073/pnas.220402097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Marmorstein AD, Stanton JB, Yocom J, et al. A model of Best vitelliform macular dystrophy in rats. Invest Ophthalmol Vis Sci. 2004;45:3733–3739. doi: 10.1167/iovs.04-0307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rosenthal R, Bakall B, Kinnick T, et al. Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J. 2006;20:178–180. doi: 10.1096/fj.05-4495fje. [DOI] [PubMed] [Google Scholar]
- 20.Wachtmeister L, Dowling JE. The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci. 1978;17:1176–1188. [PubMed] [Google Scholar]
- 21.King-Smith PE, Loffing DH, Jones R. Rod and cone ERGs and their oscillatory potentials. Invest Ophthalmol Vis Sci. 1986;27:270–273. [PubMed] [Google Scholar]
- 22.Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002;43:1673–1685. [PubMed] [Google Scholar]
- 23.Holder GE. Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol. 1987;71:166–171. doi: 10.1136/bjo.71.3.166. [DOI] [PMC free article] [PubMed] [Google Scholar]